Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RePPAIR: Ropivacaine for bone marrow procedure pain in pediatric neuroblastoma
NCT02924324Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Oct 2016
- Primary completion
- Nov 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of ropivacaine in procedural pain (2 arms), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Number of Participants Requiring Post-procedural Opioid Analgesia Per Study Arm at 24 hours. Started Oct 2016; status: completed.
02
Drugs
ropivacaine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT02924324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02924324.